Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA079656-02
Application #
6137689
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Malone, Winfred F
Project Start
1999-01-01
Project End
2003-12-31
Budget Start
2000-01-01
Budget End
2000-12-31
Support Year
2
Fiscal Year
2000
Total Cost
$96,901
Indirect Cost
Name
University of Connecticut
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
City
Storrs-Mansfield
State
CT
Country
United States
Zip Code
06269
Godman, Cassandra A; Joshi, Rashmi; Tierney, Brendan R et al. (2008) HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling. Cancer Biol Ther 7:1570-80
Wang, Hongwei; Cheng, Fengdong; Cuenca, Alex et al. (2005) Imatinib mesylate (STI-571) enhances antigen-presenting cell function and overcomes tumor-induced CD4+ T-cell tolerance. Blood 105:1135-43
Tong, Xin; Yin, Lei; Joshi, Shree et al. (2005) Cyclooxygenase-2 regulation in colon cancer cells: modulation of RNA polymerase II elongation by histone deacetylase inhibitors. J Biol Chem 280:15503-9
Place, Robert F; Noonan, Emily J; Giardina, Charles (2005) HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha. Biochem Pharmacol 70:394-406
Place, Robert F; Noonan, Emily J; Giardina, Charles (2005) HDACs and the senescent phenotype of WI-38 cells. BMC Cell Biol 6:37
Tong, Xin; Yin, Lei; Washington, Raymond et al. (2004) The p50-p50 NF-kappaB complex as a stimulus-specific repressor of gene activation. Mol Cell Biochem 265:171-83
Tong, Xin; Yin, Lei; Giardina, Charles (2004) Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition. Biochem Biophys Res Commun 317:463-71
Place, Robert F; Haspeslagh, Derek; Giardina, Charles (2003) Induced stabilization of IkappaBalpha can facilitate its re-synthesis and prevent sequential degradation. J Cell Physiol 195:470-8
Aizu, Wataru; Guda, Kishore; Nambiar, Prashant et al. (2003) p53 and its co-activator p300 are inversely regulated in the mouse colon in response to carcinogen. Toxicol Lett 144:213-24
Inan, M S; Rasoulpour, R J; Yin, L et al. (2000) The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology 118:724-34